# Rafael Díaz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rafael-diaz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 79,066 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 112 |
| i10-index | 242 |
| Last Known Institution | Estudios Clínicos Latinoamérica |
| OpenAlex ID | https://openalex.org/A5013408607 |
| ORCID iD | https://orcid.org/0000-0003-2181-9579 |
| Works | 381 |

## Researcher papers

Showing 12 of 33.

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome](https://scholariq.org/papers/alirocumab-and-cardiovascular-outcomes-after-acute-coronary-syndrome/)
- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction](https://scholariq.org/papers/efficacy-and-safety-of-low-dose-colchicine-after-myocardial-infarction/)
- [Spironolactone for Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/spironolactone-for-heart-failure-with-preserved-ejection-fraction/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome](https://scholariq.org/papers/lixisenatide-in-patients-with-type-2-diabetes-and-acute-coronary-syndrome/)
- [Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study](https://scholariq.org/papers/global-and-regional-effects-of-potentially-modifiable-risk-factors-associated/)
- [Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study](https://scholariq.org/papers/modifiable-risk-factors-cardiovascular-disease-and-mortality-in-155-722/)
- [The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study](https://scholariq.org/papers/the-effect-of-physical-activity-on-mortality-and-cardiovascular-disease-in-130/)
- [Effect of Nesiritide in Patients with Acute Decompensated Heart Failure](https://scholariq.org/papers/effect-of-nesiritide-in-patients-with-acute-decompensated-heart-failure/)
- [Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Estudios Clínicos Latinoamérica](https://scholariq.org/institutions/estudios-clinicos-latinoamerica/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.